Search Weight Loss Topics:

Page 423«..1020..422423424425..430440..»

Home » Page 423

Burundis Francine Niyonsaba, the 2016 Olympic 800m silver medalist who cannot race that distance anymore unless she takes testosterone-suppressing measures, ran an Olympic qualifying time in a different event, the 5000m, on Tuesday.

Niyonsaba clocked 14:54.38 at a meet in Montreuil, France, easily clearing the Olympic standard of 15:10.

No other woman from Burundi has ever run 15:10, according to World Athletics. A nation can qualify no more than three athletes to the Games in track and field events.

All three of the Rio Olympic 800m medalists Caster Semenya, Niyonsaba andMargaret Wambui said they are impacted by a rule instituted in 2019 that caps testosterone levels in womens events from 400m through the mile for athletes with differences of sexual development (DSD). World Athletics said that no female athletes would have a level above the cap five nanomoles per liter unless they had a DSD or a tumor.

Niyonsaba, 28, announced in February that she was moving up to the 5000m for a Tokyo Olympic bid. She ran her first 5000m on May 22 in 15:12.08, then the fastest recorded time for a woman from Burundi, according to World Athletics.

Semenya also moved up to the 5000m this year with a best time so far of 15:52.28. Semenya can also qualify for the Olympic 5000m via world ranking if she does not hit the 15:10 standard but reportedly said in April that its not about being at the Olympics.

Its being healthy and running good times and being in the field for the longest, the 30-year-old said, according to multiple reports. We had to look into can we do 200m for the next five years? It was not really in our favor. Im getting old Im scared to tear my muscles. We had to sit down and make sure that the decision that we make makes sense. Distance makes sense.

OlympicTalk is on Apple News. Favorite us!

Read the original here:
Francine Niyonsaba, who changed events due to testosterone rule, runs Olympic qualifier - Home of the Olympic Channel

Read More..

THURSDAY, June 3, 2021 (HealthDay News) -- Testosterone therapy can improve non-alcoholic fatty liver disease (NAFLD) in obese men with functional hypogonadism and type 2 diabetes, according to a study presented May 25 at the 23rd European Congress of Endocrinology.

Kristina Groti Antonic, M.D., Ph.D., from the University of Ljubljana in Slovenia, and colleagues examined the effects of testosterone therapy on morphology and grade of NAFLD in a two-year trial involving 55 obese men with functional hypogonadism and type 2 diabetes. Participants were randomly assigned to receive 1,000 mg of testosterone undecanoate (TU) for both years of the study or to receive placebo in the first year and TU in the second year (28 and 27 participants, respectively).

The researchers found that after two years of TU, liver assessment showed statistically significant improvement in NAFLD grades. Testosterone therapy normalized testosterone levels within the first year, and after the second year of the study, they remained in the normal range. During the two-year trial, there were no adverse events or side effects for TU.

"Our study shows that testosterone therapy could be used as a suitable therapy for obese men living with non-alcoholic fatty liver disease, and therefore the findings can be used to tackle this growing pandemic," Groti Antonic said in a statement.

Abstract

More Information

Original post:
e-ECE: Testosterone Therapy Mitigates NAFLD in Obese Men With FH, T2D - HealthDay News

Read More..

Testosterone BoosterMarket Scenarios and Brief Industry Analysis with Size, Status, and Forecast 2020-2026 | Covid-19 Impact Analysis

The report titled Global Testosterone Booster Market 2021 provides an in-depth analysis of different attributes of industries such as key factors affecting global and regional markets, size, status, policies, clients operating in several regions, opportunities, industry-specific trends, and effective business outlook. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners, and industry experts. This research report also provides pre & post COVID-19 impact analysis of the Testosterone Booster industry.

The Global Testosterone Booster Market size will grow from xxx Million USD in 2020 to xxxx Million USD before 2026 and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast period is projected from 2021 to 2026.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth.

https://www.theresearchinsights.com/request_sample.php?id=406072&Mode=AKG8

This market research reports analyze the growth prospects for the key vendors operating in this market space including:

Testofuel, GNC, TestoTEK, Prime Male, TEK Naturals, TestoGen, Prime Male, Nugenix, Others.

In addition to the complete assessment of the market, the report presents Future trends, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry-validated market data.

This report segments the Testosterone Booster market on the basis of Types that are

by Component

D Aspartic Acid

Vitamin D3

Other

by Source

Mucuna Pruriens

Ginseng

Oyster Extract

Fenugreek

Stinging Nettle

On the basis of Application, the Testosterone Booster market is segmented into

Teenagers

Adults

https://www.theresearchinsights.com/ask_for_discount.php?id=406072&Mode=AKG8

Regional outlook:The regions covered in the reports of the Testosterone Booster market are

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa, etc.)

Key Offerings:

https://www.theresearchinsights.com/reports/Global-Testosterone-Booster-Market-Analysis-20162020-and-Forecast-20212026-406072?Mode=AKG8

Years considered for this report:

Historical Years: 2015-20120

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2021-2026

*If you need anything more than these then let us know and we will prepare the report according to your requirement.

COVID-19 Impact:

The report covers the Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the AI to Novel Coronavirus (COVID-19) and Epidemic market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

About us:

The Research Insights A global leader in analytics, research, and advisory that can assist you to renovate your business and modify your approach. With us, you will learn to take decisions intrepidly. We make sense of drawbacks, opportunities, circumstances, estimations, and information using our experienced skills and verified methodologies. Our research reports will give you an exceptional experience of innovative solutions and outcomes. We have effectively steered businesses all over the world with our market research reports and are outstandingly positioned to lead digital transformations. Thus, we craft greater value for clients by presenting advanced opportunities in the global market.

Contact us:

Robin (Sales manager) The Research Insights

Contact number: +91-996-067-0000

+44-753-718-0101

+1-312-313-8080

sales@theresearchinsights.com | https://www.theresearchinsights.com

Visit link:
Testosterone Booster Market Specifications, Types, Growth Factors Analysis and Demand Outlook 2021 to 2026 The Manomet Current - The Manomet Current

Read More..

Image Source : FILE IMAGE

When it comes to men, what works best for sexual health

A man's sexual health, like any other subset of health, is linked to a whole variety of good lifestyle choices. Narratives of these subsets often create the illusion that one part can be improved, without overall improvement in these choices, an outcome of the unfortunate perception of the body as the sum of independent parts, as opposed to being one holistic system. Here's a path at home to better sexual health involves some classic choices that go with a healthy lifestyle.

Sound Sleep and Regular Exercise

Data at Misters reveals that 31.7 per cent of people who have good sleep -- regularly more than seven hours-- have high erection confidence, while only 18 per cent of people who sleep less than five hours a night have similar confidence about their erection. Similarly 19.5 per cent of men who do not exercise regularly report ideal ejaculation experience--in terms of duration of intercourse--while 27 per cent of people who get some exercise report a similar experience, there is sufficient clinical research that establishes the causation implied here.

Therefore the ideal steps to take towards better sexual health for men are steps that are good for their overall health. The general advice, 'sleep well, and get some exercise regularly', seems to hold true for sexual health as well. Interestingly, getting some exercise itself is likely to improve the quality of sleep, so that might be the best first step. Other ways to improve sleep include eating dinner early, and cutting down on caffeine--so limiting tea, coffee or soft drink consumption.

Ayurveda is the Key to Better Sexual Health

This is one reason why Ashwagandha is often suggested for better sexual health in Ayurveda. Given its clinically studied action to reduce stress, it helps with the quality of sleep, and is probably a great addition to your daily routine. While it is not part of a regular diet, there are some great OTC formulations like Ashwagandha Pro that can be consumed regularly for both direct and indirect improvements in sexual health.

Lack of sleep, and a greater need for sleep to function well, is also often caused by a drop in free testosterone, the male hormone. It has been established that testosterone peaks in men in early adulthood, and starts declining at the rate of 1 per cent a year from around age 40. Testosterone also has a direct impact on sexual function, with very low levels being associated with a drop in libido, reduction in number of morning erections, and other such challenges which include seventeen signs of male ageing (as established from the Ageing Male Symptoms (AMS) questionnaire) that also include stress, anxiety, loss of strength, and increase in aches and joint pain.

It is no surprise that one of the other most widely used Ayurvedic ingredients to improve sexual health is Shilajit, which is known to improve free testosterone and therefore is a great option for improvement in sexual function.

Ayurveda is of course a comprehensive system, rather than a set of symptomatic treatments, and therefore any ayurvedic expert, after careful questioning will typically draw up a diet plan that includes both foods to include in, and those to exclude from, a person's diet for holistic improvement.

Yoga to Boost Sex Drive

Most Ayurvedic experts also suggest adding yoga to the regular routine for improvement in sexual function. A few Yoga asanas like Kumbhakasana (Plank Pose), Dhanurasana (Bow Pose), Uttanapadasana (Raised Leg Pose), Paschimottanasana (Seated Forward Bend), Naukasana (Boat Pose) are associated with improvement in sexual function but these should be attempted only as part of a comprehensive yoga plan, defined by an expert.

Summing Up!

Better sexual health is often about better health!

Excerpt from:
When it comes to men, what works best for sexual health - India TV News

Read More..

Mercia Safer Neighbourhood Team/Facebook

A neighbourhood policing group made the parents of young party-goers clean up the mess left on a football field.

The parents of a gang of testosterone-fuelled youths were handed rubbish bags and ordered by police to clean up the aftermath of a party on a football field in the United Kingdom.

Police came across a trail of wanton destruction on a football field in Derbyshire, England, at the weekend, following an unauthorised party.

In a post online, a community neighbourhood team, which is part of the Derbyshire Police, said a gang of testosterone-fuelled youths turned up to a local football club and held an impromptu unofficial open-air party, leaving a trail of wanton destruction, litter and vomit behind.

Mercia Safer Neighbourhood Team said that the Hilton Harriers Football Club did not give permission for the party, and that a number of parents had somewhat unbelievably pre-arranged to drop their children off at the field, some driving long distances to do so.

READ MORE:* We bought a hill, now what? The past and future of Te Ahu Ptiki* Suspected drink-driver went on joyride after keys left in patrol car's ignition* Found on Fortnite, groomed on Snapchat it's every parent's nightmare* Is your school burning fossil fuels? Even the Government may not know

... It was very disappointing when officers attended the location, to see that the facilities had been covered and strewn with alcohol bottles, beer cans and other after-dark materials, the policing team said.

As a result, the parents of the children involved were called by police, and they and their children were given rubbish bags and ordered to clean up the mess.

Mercia Safer Neighbourhood Team/Facebook

A neighbourhood policing team posted a harsh message online to the youths who left a mess on a UK football field.

A number of other youths who fled the incident can expect visits from officers in the coming days, the post said.

According to the BBC, the parents of at least four boys, aged 15 and 16, were called to the field. No-one was arrested and no fines were issued, the BBC reported.

Follow this link:
UK police order the parents of a 'gang of testosterone-fuelled youths' to clean up party mess - Stuff.co.nz

Read More..

This article was originally published here

Prostate Cancer Prostatic Dis. 2021 Jun 4. doi: 10.1038/s41391-021-00398-1. Online ahead of print.

ABSTRACT

BACKGROUND: Evidence suggests that prostate cancer (PC) patients undergoing androgen deprivation therapy (ADT) are at risk for cognitive decline (CD), but the underlying mechanisms are less clear. In the present study, changes in cognitive performance and structural brain connectomes in PC patients undergoing ADT were assessed, and associations of cognitive changes with endocrine status and risk genotypes were explored.

METHODS: Thirty-seven PC patients underwent cognitive assessment, structural MRI, and provided blood samples prior to ADT and after 6 months of treatment. Twenty-seven age- and education-matched healthy controls (HCs) underwent the same assessments. CD was determined using a standardized regression-based approach and defined as z-scores -1.64. Changes in brain connectomes were evaluated using graph theory. Associations of CD with testosterone levels and genotypes (APOE, COMT, BDNF) were explored.

RESULTS: Compared with HCs, PC patients demonstrated reduced testosterone levels (p < 0.01) and higher rates of decline for 13 out of 15 cognitive outcomes, with three outcomes related to two cognitive domains, i.e., verbal memory and visuospatial learning and memory, reaching statistical significance (p 0.01-0.04). Testosterone level changes did not predict CD. COMT Met homozygote PC patients evidenced larger reductions in visuospatial memory compared with Val carriers (p = 0.02). No between-group differences were observed in brain connectomes across time, and no effects were found of APOE and BDNF.

CONCLUSIONS: Our results indicate that PC patients undergoing ADT may evidence CD, and that COMT Met homozygotes may be at increased risk of CD. The results did not reveal changes in brain connectomes or testosterone levels as underlying mechanisms. More research evaluating the role of ADT-related disruption of the dynamics of the hypothalamic-pituitary-gonadal axis is needed.

PMID:34088994 | DOI:10.1038/s41391-021-00398-1

See the original post:
Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypes - DocWire News

Read More..

FRIDAY, June 4, 2021 (HealthDay News) -- Patients with advanced prostate cancers may have newfound hope: Researchers identified a new potential treatment for men with metastatic castration-resistant prostate cancer, which has no cure.

Metastatic castration-resistant prostate cancer means the disease continues to spread despite therapies that deplete male hormones (androgens) such as testosterone, which are thought to "feed" tumors.

When added to standard care, this novel targeted radiotherapy improved survival for these cancer patients, researchers report.

The study "offers the treatment possibility where there was really very little for the most advanced patient, but it opens a doorway for exploring the benefits of this drug in multiple earlier patient populations," said Dr. Michael Morris, head of the Prostate Cancer Section at Memorial Sloan Kettering Cancer Center in New York City.

In about 80% of prostate cancers, there is a protein on the surface of the cancer cell that is called prostate-specific membrane antigen (PSMA). It is also distributed on prostate cancer that has spread to the bone, lymph nodes or soft tissues. Yet, PSMA is not on normal tissues, so it was a good target for both diagnostics and therapeutics, Morris explained.

The new drug has two components, a targeting molecule and a payload delivers radiation. It is given intravenously.

"Each of the molecules of drug is seeking to bind with the cells containing PSMA, which generally are the prostate cancer cell. As the drug binds to it, the cell brings the drug into the interior of the cell. The radiation, which is attached to the drug, it's the payload of the drug, is also brought into the interior of the cell. And there, it irradiates the cell and kills it as well as the cells that are neighboring to it," Morris said.

To be a part of the trial, the patients had to have disease that had progressed through testosterone-lowering therapy, which has been the standard for decades, Morris said. They also had to have progressed through another class of drugs known as androgen-receptor pathway inhibitors and through chemotherapy.

"What happens when you go on to treatment with prostate cancer is that if you respond, you stay on that therapy or stay on that regimen until either side effects preclude continuing the therapy or it no longer works because the disease has become resistant to it," Morris explained.

The trial included 831 participants. Patients were randomized two-to-one to receive the new treatment, called lutetium-labeled PSMA-617, plus standard care or just standard care between June 2018 and October 2019.

The new treatment increased overall median survival to 15.3 months versus 11.3 months for these patients who had very advanced disease. It also increased a measure called radiographic progression-free survival, which reflects disease control while on the drug, from a median of 3.4 months to 8.7 months.

The study is being presented online at the American Society of Clinical Oncology annual meeting, which will be held June 4-8. Findings presented at medical meetings are considered preliminary until published in a peer-reviewed journal. Drug maker Novartis funded the study and plans to submit the data to regulatory authorities for review and potential approval.

Prostate cancer is both the most common cancer in American men and the second leading cause of cancer-related death. The study's positive results mean that patients who have very advanced disease might have a new treatment option.

"It also means that, usually in prostate cancer as well as other diseases, what you develop and discover as a new therapy for the most advanced patients usually benefits earlier patients and frequently we'll see those benefits amplified in less sick patients who have less-resistant disease," Morris said.

Current studies are now looking at the therapy for patients who have earlier disease who have not yet received chemotherapy, as well as those who are just beginning treatments for prostate cancer.

Dr. Ash Tewari, system chair in the Milton and Carroll Petrie Department of Urology at Mount Sinai Health System in New York City, said the study offers a lot of promise for patients, giving those with advanced prostate cancer new hope. It also has a reasonable side effect profile, said Tewari, who was not involved in the study.

"Androgen deprivation is the mainstay of therapy of advanced prostate cancer, but the cure rate is low and patients eventually become castrate-resistant," Tewari said. "There is a need to more closely tailor therapies to individual patient profiles."

Noting the median results for overall survival that the study found, Tewari said that extra four months of life can be very meaningful for someone who lives to see an important family milestone, such as a grandchild's wedding.

"This is a good example of when a well-conducted clinical trial backed by scientific data can make an impact in patient's life. And we should always be curiously, cautiously looking at these options," he said.

More information

The U.S. National Cancer Institute offers more on prostate cancer.

SOURCES: Michael Morris, MD, medical oncologist, head, Prostate Cancer Section, Memorial Sloan Kettering Cancer Center, New York City; Ash Tewari, MD, professor and system chair, Milton and Carroll Petrie Department of Urology, Mount Sinai Health System, New York City; 2021 American Society of Clinical Oncology annual meeting, June 4-8, 2021

See the rest here:
Targeted Radiotherapy Might Help Men Battling Advanced Prostate Cancer - HealthDay News

Read More..

Thousands of men are set to benefit from a new prostate cancer drug which has been approved for use on the NHS.

The National Institute for Health and Care Excellence (Nice) has recommended enzalutamide as an option for treating some types of the disease.

Prostate Cancer UK said the news was welcome for thousands of men, especially those who are unable to have chemotherapy.

The drug has been used during the pandemic as a so-called "COVID-friendly" cancer drug, which patients can take at home instead of needing intravenous medication in a health setting.

Now new draft guidance from Nice should enable wider use.

Subscribe to the Daily podcast onApple Podcasts,Google Podcasts,Spotify,Spreaker

The guidance says the drug, also known as Xtandi and made by Astellas, can be used with androgen deprivation therapy (ADT), as an option for treating hormone-sensitive metastatic prostate cancer in adults.

Angela Culhane, chief executive at Prostate Cancer UK, said: "This is fantastic news for thousands of men with advanced prostate cancer, especially those who have additional illnesses that make them unsuitable for chemotherapy.

"It finally guarantees them access to a treatment which is just as effective as chemotherapy and can give them back precious time with their families."

There are an estimated 8,500 men who will be able to access the drug, which works by blocking the effect of the hormone testosterone on prostate cancer cells.

Without testosterone, the prostate cancer cells cannot grow, even if they have spread to other parts of the body.

Clinical trials have shown that the treatment increases the time until the disease gets worse and how long people live.

Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation at Nice, said: "Enzalutamide plus ADT offers another option for people with hormone-sensitive metastatic prostate cancer, especially for people who cannot have docetaxel, or who choose not to have it because of its side effects."

Go here to see the original:
Prostate cancer: Thousands of men to benefit from new drug approved for use on NHS - Sky News

Read More..

Samuel Long is a Denver teacher advocating to incorporate gender inclusive biology in high school curriculum. Photo courtesy of Samuel LongCelebrating Denver Pride: Community, Resilience, and Change

Samuel Long has a history of working for equity for LGBTQ students and staff in education. His work on gender inclusive biology carries on that tradition.

Samuel Long had always loved science. But in 2015, when he began his career as a high school biology teacher at DSST Stapleton High School (now called DSST Montview High School), he started to notice details in the curriculum that didnt sit right with him. Classroom materials never defined the difference between sex and gender, for example, and they consistently used words like male and female without much nuance. Readings called testosterone a male hormone even though it plays a role in every persons development, Long says.

At first, Long didnt say anything. This was how biology had been taught for a long time, after all, and he figured students wouldnt be interested in digging deeper into research about the complexities of gender and sex.

But then, during one lesson, a reading referred to intersex chromosomal arrangementssex chromosomes other than XX or XYas disorders of sexual development. The phrasing, while accepted in some medical literature, obscured the robust debate being had amongst researchers, doctors, and advocates about the proper way to classify members of the intersex community. Many argue that the phrase disorder carries a negative connotation and obscures the fact that some intersex people live perfectly happy and healthy lives. Others point out that certain chromosomal variations do lead to health consequences, like short stature and heart defects associated with Turner syndrome (when a female is missing some or all of an X chromosome).

Long didnt want to gloss over those conversations or risk alienating or invalidating his intersex and transgender students, including those who were not yet out. So, one day in 2015, he began class by telling students that sex and gender are separate, and that both can be on a spectrum. He was nervous, but the class was unfazed.

I remember that day was the first time I had ever heard about chromosomes as they really are, says Max Gregg, then a student in Longs class. There is all of this complication. And you can actually wind up having an unusually high number of sex chromosomes and have a completely normal and human life.

And thus, an initiative to change how biology is taught was born.

The high school biology curriculum most teachers and schools use still takes a highly binary approach to sex, gender, and sexuality, even though scientists are learning more about how complex these topics can be. Students themselves, Long says, can undoubtedly see the shades and colors of sex, gender, and sexuality all around them.

Teaching biology the traditional way can leave students who arent straight or cisgender confused, isolated, disenfranchised, and disinterested in engaging in the classroom, Long says. According to the Gay, Lesbian, and Straight Educators Network (GLSEN)s 2013 National School Climate Survey, LGBT high school seniors were more likely to be interested in studying STEM (Science, Technology, Engineering, or Math) in college if their relevant high school classes had included positive LGBT content (35.8% vs. 18.5%). The report also noted that LGBT students at schools with inclusive curricula were less likely by about half to have missed school in the past month and felt more connected to the school community.

Reading materials that emphasize that the male/female binary is rooted in biology can lead to more prejudice against trans people, according to research published in 2018.

A 2019 study from Colorado Springs BSCS Science Learning (the nonprofit studies and improves science curricula and instruction), came up with a similar finding: Something as simple as teaching high school students about plant sexual differences made students more likely to believe in neurogenetic essentialismthe idea that the differences between men and women can be solely attributed to innate, biological variations in their genes and brains, even though most researchers agree that external factors like societal expectations play a role. One problem with neurogenetic essentialism? It can often lead girls to believe incorrectly they arent well-suited for science. Its validating a broader cultural idea theyve acquired by growing up in our sexist society, says Brian Donovan, a senior research scientist at BSCS that worked on the study. The kids take that knowledge, and it reinforces their underlying ideas about gender.

Thats why, in 2019, Long and two other biology teachers (Lewis Stellar, in Seattle, and River Suh, in San Francisco) co-founded Gender Inclusive Biology (GIB), an initiative aimed at developing, promoting, and training educators on teaching biology in a way that is inclusive of LGBTQ identities. They run a website with resources for other teachers, curate a monthly newsletter that reaches 322 educators across the United States, and lead workshops for educators, curriculum developers, and administrators both privately and at conferences.

GIBs tools provide educators with actionable, accurate methods for making the curriculum more inclusive. The language guide, for example, points out binary terminology normally used in textbooks and classrooms, such as Women produce eggs and men produce sperm. The guide suggests focusing on the organ, functional activity, or role, instead of gender. So, a teacher might say ovaries produce eggs. Its scientifically accurate, and wont leave a young trans woman feeling less-than.

Long knows all too well the challenges of being a trans kid in non-supportive environments. When he came out as a transgender man in high school and began gender-affirming treatments, he faced push-back from his schools principal. She said you shouldnt use the boys bathroom because youre not a boy. But you shouldnt use the girls bathroom because your appearance is going to scare other girls. And so that didnt leave me with any options, Long says.

After graduating in 2009 from Don Mills Collegiate, a high school in Toronto, Canada, he got in touch with the Ontario Human Rights Legal Support Center and filed a lawsuit against the school. The suit was settled out of court, but Long says it created change for other students like him. The school district had to create a policy for exactly how to accommodate trans students in restrooms and other places, Long says. The school district declined to comment.

That victory showed Long the benefits of advocacy. When he moved to Colorado to start his first teaching job, he surprised himself by coming out to the staff the summer before classes started. I didnt expect that I would do that so soon. But I really felt in the midst of all these icebreakers and reflectiveness and getting to know people, that it was what I wanted to do. His fellow teachers reactions were positive, and with the support of the principal, Long decided he would come out to not only his students but to the whole school that November.

The school invited the students parents and family members to an assembly about transgender issues. There, Long came out, taking care to teach the students the correct definition of transgender and making it clear that his story was personal to him, not universal. I rehearsed what I said so much that I even remembered it the next year and said the same thing, Long says.

Some students watched silently. Others snapped emphatically in support when Long mentioned returning to his high school to file a lawsuit and became even more emphatic when he told them he won and got to consult on creating new policies for the district. Several students and parents came up afterward to shake his hand. Later, Long met with some queer-identifying students who wanted to ask more questions.

Long points out that many of the themes of his story resonate with high school students. He tells them about his arguments with his mom. She would say Im losing you. And that just made no sense to me because I was right there. But I realized that she couldnt see me for who I was, Long says. I think a lot of high schoolers have an experience where they arent being seen for who they are. And similarly, I think a lot of people in high school can relate to this idea of having to live with injustice, and trying to think about what you can do about it.

Along that vein, Long advocates for the rights of trans educators. Trans teachers fill a role that nobody else really can, which is to show young people who are trans or questioning that its possible to have a happy life, Long says. But he knows many who moved to tutoring or left teaching entirely because of pushback when they wanted to come out. Thats a big loss for schools in Colorado, he says.

To make sure more trans teachers can be true to their identities at work, Long founded the Colorado chapter of the Transgender/Nonbinary Educators Network (TEN). Last year, TEN successfully advocated for a change to Colorados Civil Rights Commission rules and regulations that meant schools cant prevent educators from being open about their gender identity.

Long and his team are just one part of a growing movement to make biology education more affirming. BSCS founded an Equity and Social Justice Initiative in 2018 that focuses on making sure science education is inclusive, relevant, and actively antiracist and anti-oppressive in all its forms. Long works with BSCS as an advisor and consultant on certain initiatives, and BSCS now uses the GIBs language guide.

Donovan, the researcher from BSCS, points out that Long is ahead of BSCSs research, but hopes to see studies done on the GIB curriculum. Do those changes when implemented in the curriculum itself lead to feelings of greater social belonging among trans students? Donovan asks.

Still, others in the education world continue to seek out Longs knowledge. He consults with textbook and curriculum developers like Gale In Context, Gale Health & Wellness databases, and OpenStax. The GIB founders have presented at conferences and written feature articles for the National Science Teaching Association. Long is currently consulting on interactive biology lab simulation software for HHMI Biointeractive, a philanthropy that creates classroom resources based on peer-reviewed science. He received and Upstander Award from the Human Rights Campaign last year, and the National Education Association awarded him the NEA Human and Civil Rights (HCR) Award, the groups highest honor, this month.

That doesnt mean GIB is free from pushback. Sometimes students or their parents ask why were learning about gender in science class, Long says. Usually, explaining that the content is scientifically accurate and inclusive quells concerns, but Long once had a GIB workshop canceled because schools were worried they might face backlash.

One teacher spoke to 5280 anonymously to avoid possible vitriol. After many years of teaching, she is adapting some of her lessons because she wants students to feel like theyre part of the community and the learning environment, not just observers, not just outsiders. She wants people to understand that educators like her arent changing the science. Were including this gender identity in the curriculum, just as we included material to empower girls, just as were including material to empower Black scientists.

She notes that she has seen queer-identified students in her class cringe and get uncomfortable when she teaches about something as simple as pedigree analysis, where the square means male, the circle means female. If a student isnt comfortable in the classroom, their ability to learn is harmed, she says. You lost them, you lost the education. And we would like to develop these future scientists no matter what their gender identity is.

Long hopes to play a part in revising the Colorado state science standards to include gender inclusive biology. He also envisions something similar to the 2019 law, HB19-1192 Inclusion Of American Minorities In Teaching Civil Government, which requires Colorado schools to teach the history, culture, and social contributions of minorities in social studies curriculum. (Long is a representative on the commission that was created by that bill.)

But for gender-inclusive biology, Long intends to take a slightly different tack. I dont know what the bill will be called or anything. It could be similar to the social studies one, but I would like to frame it as a standard of quality in some way. To teach biology in a way that doesnt acknowledge gender and sexual diversity is not the traditional way. Its of inferior quality and care to our students.

Here is the original post:
Can This Denver Teacher Make Biology Class More Inclusive? - 5280 | The Denver Magazine

Read More..

Global Testosterone undecanoate Market By Type (Injection,Oral), By Application (Primary hypogonadism,Hypogonadotropic hypogonadism,Late-onset hypogonadism) Geography (North America (United States, Canada and Mexico), South America (China, Japan, Korea, India and Southeast Asia), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), Middle East and Africa (Saudi Arabia, Egypt, Nigeria and South Africa)) Industry Trends 2021-2028

Market overviewThis market report on Testosterone undecanoate can help the companies to make crucial business plans on production techniques, raw materials procurement, and to increase the industry chain cycle of the market globally. The case study report on Testosterone undecanoate is a brief history and a detailed assessment of the Testosterone undecanoate market 2021 including key company profiles, and overall competitive scenario, key market trends, upcoming technologies, industry drivers, challenges, regulatory policies.

Request a sample Report of Testosterone undecanoate Market @ https://www.statistifymarketresearch.com/reports/testosterone-undecanoate-market/sample-request-87689

MethodologyThe research work involved the usage of both primary and secondary data sources. The research methods involved the study of many points affecting the industry, including government guidelines, market surroundings, combative landscape, past data. Primary and Secondary research are the two methods that are used for the survey purpose. The primary sources consist of having interviews with many industry experts, suppliers, and other specialists. The secondary sources consist of an analysis of empirical data from press releases, government-designed websites, yearly reports of the companies, and other related documents. Other fields of the examination are modern shifting in the market, technological invention, upcoming technologies, and the technical enhancement in related industries, market risks, opportunities, hindering, and risks in the operating market. The Data acquirement phase involves gathering and merging market information and data related with the help of various sources and research processes. Structured databases such as D&B Hoover and Bloomberg are used which helps to recognize the competitive environment of top market players along with profile details.

Regional AnalysisAny type of report on Testosterone undecanoate is a highly valuable and important tool for any business association regardless of the scale on which it operates in the sector. It provides a source to track and examine the performance and overall condition of the business while also identifying fields that has the scope for improvement for the better functioning of the organization. A well-prepared business report also holds great value as it suggests preventive measures that need to be done to avoid the business fails to meet the desired targets and thus helps to recover from the adversities. An annual report on Testosterone undecanoate prepared in the company is an effective tool for providing employees, investors, and other clients with a complete picture of their business.

Customization of the Report: The customized report is provided by our consultancy at a reasonable price. We provide updated information according to the requirements of the customers in the market world.

Top Listed Companies in the Testosterone undecanoate Market Include

Bayer AG,Taro Pharmaceutical,Endo Pharmaceuticals,Zhejiang Medicine Co.,Merck Sharp & Dohme,Zhejiang Xianju Pharmaceutical,Cipla

Reasons to buy this Report:It helps in understanding the major key product segments.This report throws on Testosterone undecanoate light on the dynamics of the market such as drivers, restraints, trends, and opportunities.It offers the regional analysis of Testosterone undecanoate Market along with business profiles of several stakeholders in the research market.It offers massive data about trending factors that will influence the progress of the Testosterone undecanoate Market.It offers an in-depth analysis of the changing competitive scenario in the Testosterone undecanoate market of the research industry.

Request for Customization @ https://www.statistifymarketresearch.com/checkout/?currency=USD&type=single_user_license&report_id=87689

Benefits:1. Well updated information.2. Statistical report provided.3. Discount offer in customization.4. Service at the global level.5. Company research report provided.

Services:1. Expert analysts at your service.2. Service according to your needs3. Clearance of your queries.4. Whole day service5. Well updated Report.

Frequently Asked Questions?Q1. What is the total market value of the Testosterone undecanoate market report?Q2. What would be the forecast period in the Testosterone undecanoate market report?Q3. What is the base year considered in the Testosterone undecanoate market report?Q4. Which are the top companies hold the market share in the Testosterone undecanoate market ?Q5. Which is expected to be the fastest growing segment in the Testosterone undecanoate market?Q6. Which market holds the maximum market share of the Testosterone undecanoate market ?Q7. How the company profile has been selected?Q8. What will be the market value of the Testosterone undecanoate market in 2028?

Full Report Summary of Testosterone undecanoate Market @ https://www.statistifymarketresearch.com/testosterone-undecanoate-market

About Statistify Market ResearchStatistify Market Research is a market research organization that endeavors to furnish all clients with the most ideal help and suggestions. Our research is exceptionally intended for your associations working in all areas and assist them with investigating viable development techniques and proposals. We dont hold fast to a uniform rule. We comprehend that your organization has explicit research necessities, and we endeavor to comprehend the subtleties of your individual research needs so we can give you concentrated research administrations.

Company Name Statistify Market ResearchOffice Address 156, Sector 9 Vasundhra Aptts Rohini,New Delhi 110085 INTelephone Numbers (+44) 162-237-1047 (+44) 162-237-1047Email ID [emailprotected]Contact Us https://www.statistifymarketresearch.com/contact-us/

Read more here:
Global Region to Remain one of The Leading Outlook for Testosterone undecanoate Market Through 2028 Clark County Blog - Clark County Blog

Read More..

Contact Us Today

Page 423«..1020..422423424425..430440..»

Home » Page 423